Ophthalmic Business Council
For more than 20 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.
OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.
To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.
Download brochures: AAO 2018 exhibitors and non-exhibitors
Save the Date
Fall 2018 Symposium
Sept. 20 to 21
Westin Gaslamp Quarter Hotel
San Diego, Calif.
Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.
Spring 2019 Symposium
April 11, 2019
Washington, DC
Held every other year, the Spring Symposium focuses on the latest first-hand from experts on FDA, Medicare and reimbursement issues. As the speed of innovation grows, this event helps you navigate the complexities of introducing new technologies and treatments to patients. Unlike the Fall Symposium, Academy leaders do not attend this meeting.
Member Benefits
2018 - 2019 Ophthalmic Business Council
Crown Benefactors ($25,000)
Alcon, Inc.
Allergan, Inc.
Genentech, Inc.
Johnson & Johnson Vision
Novartis Pharmaceuticals
Optos, Inc.
Regeneron Pharmaceuticals, Inc.
Shire
Verana Health
Benefactors ($15,000)
Bausch + Lomb
Patrons ($7,500)
Boehringer Ingelheim
Carl Zeiss Meditec, Inc.
Horizon Pharma
Mallinckrodt Pharmaceuticals
Omeros Corporation
Sun Ophthalmics
Subscribers ($5,000)
Aerie Pharmaceuticals, Inc.
Akorn, Inc.
Bio-Tissue, Inc.
Clearside Biomedical, Inc.
Glaukos Corporation
Notal Vision, Inc.
REGENXBIO, Inc.
Santen, Inc.
Spark Therapeutics, Inc.
Members ($2,500)
Alimera Sciences, Inc.
Apellis Pharmaceuticals
ASICO, LLC
Aura Biosciences, Inc.
Heidelberg Engineering
MicroOptix
NeoMedix Corporation
New World Medical, Inc.
Ocunexus Therapeutics
ThromboGenics, Inc.
Topcon Medical Systems, Inc.
Zydoc Medical Transcription